Big compounders will have until May 22 to stop producing and dispensing compounded semaglutide, while smaller, state-run ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Novo Nordisk filed for approval of an oral, 25-mg formulation of its weight loss blockbuster “earlier this year,” according ...

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

The injectable forms of semaglutide — Ozempic for diabetes and Wegovy for weight loss — have solid evidence backing up their claims of cardiovascular protection. The oral form, marketed as ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Compounding pharmacies have been allowed to make generic semaglutide — the active ingredient in the blockbuster drugs — due to a short supply of the brand name medications that started in 2022.

In May 2023, when Novo reported that patients on the highest dose (50 mg) of oral semaglutide lost 15% of their weight after 64 weeks, the company said it planned to apply for approval by the end ...

"We are fortunate to have timed this release during industry downturn and economic challenges alongside the disruption to non-invasive body contouring demand by that of semaglutide and the heavily ...

Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...